Antiepileptic drugs in Posttraumatic Stress Disorder

Clinical Neuropharmacology

Volumn 25, Issue 4, 2002, Pages 225-229

  Iancu, Iulian ^a   Rosen, Yitzhak ^a   Moshe, Kotler ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antiepileptic drugs; Controlled studies; Kindling; Posttraumatic stress disorder; Tolerability

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOMIPRAMINE; GABAPENTIN; LAMOTRIGINE; THIORIDAZINE; TOPIRAMATE; TRIMIPRAMINE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN;

ARTICLE; BLOOD DYSCRASIA; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; IRRITABILITY; KINDLING; LIVER TOXICITY; NEUROBIOLOGY; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SIDE EFFECT; VERTIGO; VOMITING;

ANIMALS; ANTICONVULSANTS; CLINICAL TRIALS; HUMANS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0036334719     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200207000-00006     Document Type: Article

References (47)

1. The psychobiology of PTSD
2. Trauma and posttraumatic stress disorder in the community
3. Biological therapies for PTSD: An overview
4. Outcomes of Posttraumatic Stress Disorder
5. Treatment of PTSD with amitryptiline and placebo
6. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder
7. Pharmacotherapy for PTSD using phenelzine or imipramine
8. Predictors of treatment response in patients with posttraumatic stress disorder
9. Fluoxetine in posttraumatic stress disorder. Randomized, double-blind study
10. Paroxetine in the treatment of chronic PTSD: Results of a placebo-controlled, flexible-dosage trial
11. Multicenter, double-blind comparison of sertraline and placebo in the treatment of PTSD
12. The efficacy and use of anticonvulsants in mood disorders
13. Transmitter systems involved in neural plasticity under-lying increased anxiety and defense implications for understanding anxiety following traumatic stress
14. Neurobiological sensitization models of posttraumatic stress disorder: Their possible relevance to multiple chemical sensitivity syndrome
15. The psychobiological basis of posttraumatic stress disorder
16. Long-term potentiation of the perforant path-granule cell synapse in the rat hippocampus
17. Kindling: Implications for the course and treatment of affective disorders
18. Mechanisms of action of anticonvulsants in affective disorders: Comparisons with lithium
19. The use of anticonvulsants in posttraumatic stress disorder: Case study and overview
20. Carbamazepine in the treatment of Lyme-induced hyperacusis
21. Posttraumatic stress disorder and partial complex seizures
22. Preliminary study of carbamazepine in Posttraumatic Stress Disorder
23. Carbamazepine for PTSD
24. Posttraumatic stress disorder in Vietnam veterans: Clinical and EEG findings; possible therapeutic effects of carbamazepine
25. Pharmacological management of Posttraumatic Stress Disorder: Clinical summary of a five-year retrospective study, 1990-1995
26. Valproate and carbamazepine in the treatment of panic, posttraumatic stress disorder, withdrawal states and behavioral dyscontrol syndromes
27. Divalproex in PTSD
28. Valproate in combat-related Post-traumatic Stress Disorder
29. Divalproex in posttraumatic stress disorder: An open-label clinical trial
30. Lamotrigine: A review of pharmacological properties and clinical efficacy in epilepsy
31. Emerging options in the treatment of bipolar disorders
32. Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder
33. A preliminary study of lamotrigine for the treatment of Posttraumatic Stress Disorder
34. New antiepileptic drugs: A systematic review of their efficacy and tolerability
35. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats
36. Topiramate in Posttraumatic Stress Disorder
37. Open-label topiramate as primary or adjunctive therapy in chronic civilian Post-traumatic Stress Disorder: A preliminary report
38. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy
39. Acute psychotic symptoms induced by topiramate
40. Gabapentin treatment for posttraumatic stress disorder
41. Vigabatrin and posttraumatic stress disorder
42. PTSD and carbamazepine
43. Comprehensive review of the psychiatric use of valproate
44. Tianeptine attenuates stress-induced morphological changes in the hippocampus
45. Phenytoin prevents stress and corticosterone-induced atrophy of CA3 pyramidal neurons
46. Kindling versus quenching. Implications for the evolution and treatment of PTSD